Michael John Sumner - 27 Feb 2023 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Chief Medical Officer
Signature
/s/ Michael John Sumner
Issuer symbol
INO
Transactions as of
27 Feb 2023
Net transactions value
$0
Form type
4
Filing time
28 Feb 2023, 16:38:25 UTC
Previous filing
06 Jul 2022
Next filing
17 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Common Stock Option Award $0 +112,500 $0.000000 112,500 27 Feb 2023 Common Stock 112,500 $1.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The vesting schedule for the 112,500 options is as follows: 28,125 shares vested on February 27, 2023; 28,125 shares will vest on February 26, 2024; 28,125 shares will vest on February 26, 2025; and 28,125 shares will vest on February 26, 2026.